To isolate methicillin resistant Staphylococcus aureus (MRSA) from anterior nares of dairy workers and dairy products and assess the antibiotic susceptibility pattern of the isolates.
INTRODUCTION
Staphylococcus aureus is considered to be one of the leading causes of food borne illness. Milk, dairy products and meats are often contaminated with this bacterium. Foodstuff contamination may occur directly from infected food producing animals or may result from poor hygiene during production processes or the retail and storage of foods, since humans may carry the microorganisms (Hennekinne et al. 2010) . S. aureus colonizes skin and mucosa of humans and animals, with nasal carriage rates between 30% and 50% among the adult human population (Sakr et al. 2018) .
While colonization of the anterior nares is usually asymptomatic, it serves as a reservoir for the spread of the organism. Carries are at increased risk to develop bacteremia which in 80% of cases is caused by the strain colonizing their nares (Hassoun et al. 2017) . The rapid emergence of antibiotic resistance among S. aureus is also known to play a crucial role in the epidemiology of staphylococcal infections (Wertheim et al. 2005) .
Methicillin resistant S. aureus (MRSA) has become an increasingly important and serious public health concern due to the morbidity, mortality and cost that is associated with these infections annually. Once exposed to MRSA, animals may become colonized, and serve as reservoirs to transmit the infection to other animals or humans. Data has shown that with human to animal transmission, there is a possibility that until the animal is free of infection, re-transmission from the animal and subsequent human to human transmission can occur (American Veterinary Medical Association 2009). Therefore, this study aims to isolate MRSA from anterior nares of dairy workers and dairy products and assess the antibiotic susceptibility pattern of the isolates. Antibiotic susceptibility pattern showed that most of the MRSA isolates were susceptible to Gentamicin followed by Ciprofl oxacin (Table 3) . 
MATERIALS AND METHODS

